Highlights:

• Neurizon announces an expansion to the size of Regimen I intended to support a larger and more informative dataset, with accelerated time to topline readout and no change in funding requirements
• Increase in sample size driven by enrolment rate exceeding original expectations and the absence of a concurrent regimen during the expected...